In vitro and in vivo anti-MRSA activities of nosokomycins
Authors:
- 1 January 2014
- journal article
- research article
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 8 (6) , 249-254
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 13 references indexed in Scilit:
- Lysocin E is a new antibiotic that targets menaquinone in the bacterial membraneNature Chemical Biology, 2014
- Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sourcesBMC Pharmacology, 2010
- Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. II: Structure elucidationThe Journal of Antibiotics, 2010
- Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological propertiesThe Journal of Antibiotics, 2010
- A small-molecule screen in C. elegans yields a new calcium channel antagonistNature, 2006
- In vivo drug discovery in the zebrafishNature Reviews Drug Discovery, 2005
- Drosophila melanogaster as a model host for Staphylococcus aureus infectionMicrobiology, 2004
- Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic MicroorganismsAntimicrobial Agents and Chemotherapy, 2004
- Silkworm larvae as an animal model of bacterial infection pathogenic to humansMicrobial Pathogenesis, 2002
- TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1995